Skip to main content

Single-cell Genomics Study Elucidates Human Cytomegalovirus Infection

 Infection of β-herpesvirus human cytomegalovirus (HCMV) could be life-threatening or cause life-long suffering in the majority of humans. Moreover, the viral vertical transmission during pregnancy leads to most congenital birth defects. However, treatment and prevention options currently available are extremely limited.

 

Challenges in Studying HCMV–host Cell Interactions

 

More than 235 kbp of double-stranded DNA (dsDNA) in HCMV makes the largest known genome of human herpesviruses. Besides, HCMV is similar to other herpesviruses with complicated transcriptional architecture, including alternative transcription start sites, alternative splicing events, and polycistronic transcripts. The complex transcriptional architecture enables strict temporal control of gene expression and the possibility of generating multiple distinct proteins from a single genomic locus. The complexity is further increased by host cellular heterogeneity and differences in infection kinetics, which is the main reason why most previous screens of virus–host interactions prefer to study the overall response to exclude HCMV or host factors during infection.

 

Update: Characterize Virus—host Interactions with Single-cell Genomics

 

A thorough comprehension of how viral and host factors interact and how perturbations impact infection is the foundation for designing antiviral interventions. A recent investigation conducted by the University of California, San Francisco researchers was published in Nature Biotechnology. This study initiated the first combined usage of single-cell sequencing and CRISPR-based genetic perturbation, which had been previously applied to oncogenesis study, to better understand HCMV—host cell interactions.

 

Single-cell CRISPR screening is a powerful technique to monitor gene expression changes in response to perturbation at a single-cell level. Single-cell CRISPR screening services now have been widely developed for researchers who focus on antiviral research in humans to potentially search for perturbed genomic elements that lead to the differential expression of genes involved in virus entry and transmission.

 

This scalable approach that combines CRISPR-based genetic perturbations with rich phenotypic profiling by single-cell transcriptomics is known as Perturb-seq. The Perturb-seq methodology can identify the impact of perturbations on individual gene targets, gene signatures, and cell states, as well as their genetic interactions, further determining how genetic perturbation of critical host and viral factors alters the timing, course, and progression of infection.

 

Researchers recorded the transcriptomes of tens of thousands of CRISPR-modified single cells and observed that, though could genetic perturbation halt, delay, or boost progression along the infection trajectory, perturbing critical host factors didn't fundamentally change the stereotypical transcriptional trajectory. It was concluded that HCMV is entirely dependent on the transcriptional and translational machinery of its host while the host gene mainly regulates the process through the deterministic infection program encoded by the viral genome.

 

Significance

 

The study of human cytomegalovirus infection using pooled CRISPR interference and nuclease screening method defined how functional viral and host factors contribute to human cytomegalovirus infection. And the first application of the Perturb-seq method in virus—host interaction characterization allows a deeper understanding of hostpathogen interactions at the single-cell level regarding other different viral, bacterial, and parasitic pathogens. Moreover, the single-cell genomics study of human cytomegalovirus infection could inspire the design of attenuated viral strains in the development of vaccine and antiviral.

 

Though it's not verified if this finding can contribute to other viral infection research, researchers believe that single-cell functional genomics is likely to serve for studying other viruses and can define their vulnerabilities to genetic or pharmacological interventions.

Comments

Popular posts from this blog

Everything You Want to Know About Antibody Development

  Everything You Want to Know About Antibody Development   When foreign molecules, which are known as antigens, enter our body, antibodies will be released by B cells of the immune system to specifically bind to the antigens and finally clear out those “invaders”. Such a highly specific molecular recognition mechanism has inspired a variety of antibody development research and diagnostic applications nowadays, including IVD antibody development .   What is Antibody Development?   Antibody development is the process of creating and characterizing an antibody.   The timeline of developing antibodies starts from the injection of an antigen of interest into a host animal, so that the host’s immune system can detect it and generat e  the desired antibodies. Then, antibody development proceeds with finding and isolating the desired antibodies from the rest of the protein in sera.   The reset procedure of antibody development is varied as the desired antibodi...

An Overview of the Global Bispecific Antibody Therapeutics Market

  Antibod ies , a major component of adaptive immunity, play a critical role in protective and pathogenic immune responses. In r ecent years, a wide range of antibodies is discovered as candidates of cancer therapeutic agents, including the reconstructive molecules, bispecific antibodies (BsAbs).   About Bispecific Antibody   Bispecific antibodies, as its name indicates, consists of two antigen-binding sites, which can simultaneously bind two separate and unique antigens (or different epitopes of the same antigen). This structure is  typically designed to bind to two targets, one on a cancer cell and one on an immune cell, act ivating or redirecting immune effector cells with the goal of getting the immune cell to kill the cancer cell by antibody-dependent cell-mediated cytotoxicity (ADCC), antibody-dependent cellular phagocytosis (ADCP), complement-dependent cytotoxicity (CDC) and other cytotoxic mechanisms.   U nique biological and pharmacological properties, ...

Unmodified Bacteriophages Research Updates

  R ecent research conducted by researchers from Yale University is published in  Applied and Environmental Microbiology , suggesting  that natural bacteriophage, or phage, can kill dysentery-causing bacteria and reduce virulence in surviving bacteria. It's a piece   of  inspiring news as  treating dysentery has become a challenge with the rising antibiotic resistance.   Background   Shigella flexneri , the culprit causing contagious infection marked by inflammatory diarrhea and dysentery in sub-Saharan Africa and southern Asia, kills about 160,000 people globally every year. The World Health Organization (WHO) takes priority to this pathogen in terms of increasing cases, antimicrobial resistance, and limited treatment options.   S. flexneri  is active primarily in low-income countries, like southern Asia and sub-Saharan Africa. In these places, dirty drinking water is a concern causing dysentery, while antibiotics are expensive and unav...